Normalization of the tumor microenvironment: evidence for tissue inhibitor of metalloproteinase-2 as a cancer therapeutic

TIMP-2 modulates cancer cell transcriptional profile and enhances E-cadherin/beta-catenin complex expression in A549 lung cancer cells

(2015) Dimitra Bourboulia et al.   Oncotarget

Serum matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in esophageal cancer patients

(2013) Magdalena Groblewska et al.   FOLIA HISTOCHEMICA ET CYTOBIOLOGICA

Association of Promoter Polymorphisms in MMP2 and TIMP2 with Prostate Cancer Susceptibility in North India

(2012) Priyanka Srivastava et al.   ARCHIVES OF MEDICAL RESEARCH

Antagonism of VEGF-A-induced increase in vascular permeability by an integrin  3 1-Shp-1-cAMP/PKA pathway

(2012) S. H. Kim et al.   BLOOD

The extracellular matrix: A dynamic niche in cancer progression

(2012) Pengfei Lu et al.   JOURNAL OF CELL BIOLOGY

Immunoreactivity for TIMP-2 is associated with a favorable prognosis in endometrial carcinoma

(2012) Maria Honkavuori-Toivola et al.   TUMOR BIOLOGY

TET1 Suppresses Cancer Invasion by Activating the Tissue Inhibitors of Metalloproteinases

(2012) Chih-Hung Hsu et al.   Cell Reports

Analysis of the MMP-dependent and independent functions of tissue inhibitor of metalloproteinase-2 on the invasiveness of breast cancer cells

(2012) Logan A. Walsh et al.   Journal of Cell Communication and Signaling

Endogenous Angiogenesis Inhibitor Blocks Tumor Growth via Direct and Indirect Effects on Tumor Microenvironment

(2011) Dimitra Bourboulia et al.   AMERICAN JOURNAL OF PATHOLOGY

Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer

(2011) T. R. Cox et al.   Disease Models & Mechanisms

Astrocytic Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Promotes Oligodendrocyte Differentiation and Enhances CNS Myelination

(2011) C. S. Moore et al.   JOURNAL OF NEUROSCIENCE

Normalization of the Vasculature for Treatment of Cancer and Other Diseases

(2011) Shom Goel et al.   PHYSIOLOGICAL REVIEWS

The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity

(2010) Keith Brew et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

The Anti-angiogenic Peptide, Loop 6, Binds Insulin-like Growth Factor-1 Receptor

(2010) Cecilia A. Fernandez et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer

(2010) Kyung Sook Park et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Metzincin Proteases and Their Inhibitors: Foes or Friends in Nervous System Physiology?

(2010) S. Rivera et al.   JOURNAL OF NEUROSCIENCE

TIMP-2 modulates VEGFR-2 phosphorylation and enhances phosphodiesterase activity in endothelial cells

(2010) Seo-Jin Lee et al.   LABORATORY INVESTIGATION

Clinical Impact of MMP and TIMP Gene Polymorphisms in Gastric Cancer

(2010) Hakan Alakus et al.   WORLD JOURNAL OF SURGERY

S156C Mutation in Tissue Inhibitor of Metalloproteinases-3 Induces Increased Angiogenesis

(2009) Jian Hua Qi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Matrix Metalloproteinases As Novel Biomarker s and Potential Therapeutic Targets in Human Cancer

(2009) Roopali Roy et al.   JOURNAL OF CLINICAL ONCOLOGY

The Extracellular Matrix: Not Just Pretty Fibrils

(2009) R. O. Hynes   SCIENCE

Tissue inhibitor of metalloproteinase-2 G-418C polymorphism is associated with an increased risk of gastric cancer in a Chinese population

(2008) L. Yang et al.   EJSO

Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities

(2008) W. G. Stetler-Stevenson   Science Signaling